Cellective Therapeutics cellectivetherapeutics.com


Public list: Pharma Startups (4740) Cancer Therapeutics (1146)

Cellective was developing several new pharmaceuticals treating B Cell related cancer and immune diseases. The technology is based on research by Founder Tom Tedder, Chairman of Immunology at Duke University.

Cellective was developing several new pharmaceuticals treating B Cell related cancer and immune diseases. The technology is based on research by Founder Tom Tedder, Chairman of Immunology at Duke University.

Company (Acquired)

Phone: 301-977-7042

Fax:

35 West Watkins Mill Road
Suite 100
Gaithersburg, 20878
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cellective Therapeutics $27.7M Oct 18, 2005
OncoMed Pharmaceuticals $376.2M Dec 6, 2018
Verus Pharmaceuticals $78M Jun 22, 2005
See all 17 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cellective Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors

Board Members

Competitors

Company Status Description Investors
See all 17 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)